Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Qhslab Inc (USAQ)

Qhslab Inc (USAQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Eton Pharmaceuticals, Inc. (ETON) Q4 Earnings Surpass Estimates Zacks - Thu Mar 16, 2023

Eton Pharmaceuticals, Inc. (ETON) delivered earnings and revenue surprises of 300% and 6.62%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

ETON : 3.71 (-1.07%)
USAQ : 0.0910 (unch)
VBI Vaccines, Inc. (VBIV) Reports Q4 Loss, Misses Revenue Estimates Zacks - Mon Mar 13, 2023

VBI Vaccines, Inc. (VBIV) delivered earnings and revenue surprises of -14.29% and 85.20%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

VBIV : 0.5900 (+1.27%)
USAQ : 0.0910 (unch)
Poseida Therapeutics, Inc. (PSTX) Reports Q4 Loss, Misses Revenue Estimates Zacks - Thu Mar 9, 2023

Poseida Therapeutics, Inc. (PSTX) delivered earnings and revenue surprises of -182.98% and 71.28%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the...

PSTX : 2.87 (+2.87%)
USAQ : 0.0910 (unch)
ObsEva SA (OBSV) Reports Q3 Loss, Lags Revenue Estimates Zacks - Thu Dec 1, 2022

ObsEva SA (OBSV) delivered earnings and revenue surprises of 7.14% and 100%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

OBSV : 0.1018 (-15.52%)
USAQ : 0.0910 (unch)
Twist Bioscience (TWST) Reports Q4 Loss, Tops Revenue Estimates Zacks - Fri Nov 18, 2022

Twist Bioscience (TWST) delivered earnings and revenue surprises of 28.91% and 0.56%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

TWST : 41.21 (+28.74%)
USAQ : 0.0910 (unch)
Immatics (IMTX) Reports Q3 Loss, Tops Revenue Estimates Zacks - Thu Nov 17, 2022

Immatics (IMTX) delivered earnings and revenue surprises of -3.23% and 13.62%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

IMTX : 10.77 (-1.10%)
USAQ : 0.0910 (unch)
Alpine Immune Sciences, Inc. (ALPN) Reports Q3 Loss, Misses Revenue Estimates Zacks - Mon Nov 14, 2022

Alpine Immune Sciences, Inc. (ALPN) delivered earnings and revenue surprises of -320% and 59.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the...

ALPN : 64.60 (unch)
USAQ : 0.0910 (unch)
Eton Pharmaceuticals, Inc. (ETON) Reports Q3 Loss, Tops Revenue Estimates Zacks - Thu Nov 10, 2022

Eton Pharmaceuticals, Inc. (ETON) delivered earnings and revenue surprises of 20% and 7.30%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

ETON : 3.71 (-1.07%)
USAQ : 0.0910 (unch)
Anika Therapeutics (ANIK) Reports Q3 Loss, Tops Revenue Estimates Zacks - Tue Nov 8, 2022

Anika (ANIK) delivered earnings and revenue surprises of -20.83% and 10.13%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

ANIK : 27.59 (unch)
USAQ : 0.0910 (unch)
Intra-Cellular Therapies (ITCI) Reports Q3 Loss, Tops Revenue Estimates Zacks - Thu Nov 3, 2022

Intra-Cellular (ITCI) delivered earnings and revenue surprises of 33.72% and 10.66%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

ITCI : 68.80 (-2.19%)
USAQ : 0.0910 (unch)

Barchart Exclusives

2 Uranium Stocks With 50% or More Upside Potential Barchart - 1 hour ago
As U.S. passes the bill to ban uranium import from Russia, U.S. based uranium companies are sure to enjoy the increased demand. Here are 2 stocks with upside according to analysts. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot